Hennion & Walsh Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,828	Closed	-$118K	–	949
2025 Q1	$118K	Sell	14,828 -3,418	-19%	-$25K	0.01%	853
2024 Q4	$99.1K	Sell	18,246 -21,172	-54%	-$129K	﹤0.01%	841
2024 Q3	$285K	Sell	39,418 -2,419	-6%	-$22.1K	0.01%	748
2024 Q2	$454K	Sell	41,837 -24,730	-37%	-$317K	0.02%	613
2024 Q1	$1.25M	Buy	66,567 +5,068	+8%	+$117K	0.07%	368
2023 Q4	$1.33M	Sell	61,499 -23,996	-28%	-$476K	0.08%	334
2023 Q3	$1.76M	Buy	85,495 +4,262	+5%	+$123K	0.11%	234
2023 Q2	$3.82M	Buy	81,233 +8,476	+12%	+$422K	0.23%	112
2023 Q1	$3.05M	Buy	72,757 +1,740	+2%	+$74.8K	0.19%	139
2022 Q4	$2.71M	Sell	71,017 -9,373	-12%	-$358K	0.17%	157
2022 Q3	$3.15M	Buy	80,390 +1,972	+3%	+$76.2K	0.21%	134
2022 Q2	$2.53M	Buy	78,418 +15,866	+25%	+$532K	0.16%	167
2022 Q1	$2.07M	Buy	62,552 +10,264	+20%	+$386K	0.11%	218
2021 Q4	$2.22M	Buy	52,288 +14,393	+38%	+$603K	0.11%	220
2021 Q3	$1.68M	Sell	37,895 -835	-2%	-$38.3K	0.09%	260
2021 Q2	$2.2M	Sell	38,730 -421	-1%	-$29.8K	0.12%	234
2021 Q1	$2.93M	Buy	+39,151	New	+$3.21M	0.18%	165